This inventor holds 2 USPTO granted patents. Top assignees: Creighton University, Centre National De La Recherche Scientifique. Active years: 1994-1997.
Company Filing History:
2 out of 69 
1 out of 5,383 
Years Active: 1994-1997
Title: J Michael Conlon: Innovator in Pharmaceutical Research
Introduction
J Michael Conlon is a notable inventor based in Omaha, NE (US). He has made significant contributions to the field of pharmaceutical research, particularly in the treatment of cancer. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
One of his latest patents is focused on the anti-tumor effects of GnRH-III. This invention provides a novel pharmaceutical composition for the treatment of breast cancer, along with various methods for treating the disease. Another important patent relates to neuropeptides of the tachykinin family, which describes a peptide characterized by a specific sequence of amino acids.
Career Highlights
Throughout his career, J Michael Conlon has worked with esteemed institutions such as Creighton University and the Centre National de la Recherche Scientifique. His research has been pivotal in advancing our understanding of cancer treatment.
Collaborations
He has collaborated with notable coworkers, including Adrienn Kalnay and Dezso Gaal, contributing to various research projects and innovations.
Conclusion
J Michael Conlon's work in pharmaceutical research exemplifies the impact of innovation in medicine. His patents and collaborations highlight his commitment to improving cancer treatment options.